临床药师参与药学监护在呼吸系统疾病雾化吸入治疗中的干预效果

Intervention effect clinical pharmacist participating in pharmaceutical care in atomization inhalation therapy for respiratory diseases

目的探讨临床药师参与药学监护在呼吸系统疾病雾化吸入治疗中的干预效果。方法选取2018年1月—2019年3月于信宜市怀乡镇中心卫生院行雾化吸入治疗的呼吸系统疾病患者110例,随机分为对照组与观察组,各55例。对照组予以常规用药监护,观察组在对照组基础上予以临床药师参与药物监护。比较两组不合理用药、不良反应发生率、服务满意度。结果观察组不合理用药率、不良反应发生率低于对照组,服务满意度高于对照组(P<0.05)。结论临床药师参与药学监护在呼吸系统疾病雾化吸入治疗中的干预效果较好,可避免不合理用药情况,降低不良反应发生率,提高患者满意度。

Objective To discuss the intervention effect clinical pharmacist participating in pharmaceutical care in atomization inhalation therapy for respiratory diseases.Methods A total of 110 cases of patients with respiratory diseases treated by atomization inhalation were selected from January 2018 to March 2019 in Huaixiang Town Central Hospital of Xinyi City,which were randomly divided into control group and observation group,55 cases in each group.The control group received routine medication monitoring,the observation group was given clinical pharmacists to participate in drug monitoring on the based of control group.Irrational drug use,incidence rate of adverse reactions,service satisfaction were compared between the two groups.Results The observation group of irrational drug use rate and incidence rate of adverse reactions were lower than control group,and the service satisfaction was higher than control group(P<0.05).Conclusion Clinical pharmacist participating in pharmaceutical care have an exact clinical effect for atomization inhalation therapy for respiratory diseases,which can avoid irrational drug use,reduce the incidence rate of adverse reactions and improve patient satisfaction.